Activation of the poly(ADP-ribose) polymerase after oxidative damage is implicated in different responses of the cells, for example, cell recovery after sublethal damage or cell death after lethal damage. However, the extent and mechanism of involvement of the enzyme in these two processes appear to be different. Inhibitors of this polymerase, such as benzamides, which do not completely inhibit PARP have been shown to protect the cells from killing by massive oxidant damage, could neither reduce the cellular recovery after mild oxidant damage nor completely inhibit DNA repair in vitro. We report here that 1,5-dihydroxyisoquinoline, which was earlier shown to be a strong inhibitor of this polymerase in vitro, is also its potent inhibitor in vivo. Using sensitive techniques for measuring low levels of cellular poly(ADP-ribose) polymer, we show that this inhibitor can completely abolish oxidant-induced activation of the polymerase in C3HlOTl/2 cells. We show that only a minor fraction of the poly(ADP-ribose) polymerase activity is sufficient in cellular recovery after sublethal oxidant damage. We also demonstrate that cells are unable to recover from oxidant damage in the complete absence of polymerase activity.
Introduction
One of the early reactions in the cell exposed to a DNA-damaging agent is activation of a post-translational modification enzyme poly(ADP-ribose) polymerase (PARP; EC 2.4.2.30). This enzyme, which is present in the higher eukaryotic nucleus in great abundance, is activated in the presence of DNA strand breaks to utilize NAD and form a polymer of ADP-ribose (pADPr) on nuclear accepAbbreviations:
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tor molecules such as histones, topoisomerase, and predominantly on itself. The polymerase is implicated in a variety of cellular responses after DNA damage by oxidants, ranging from cell survival after sublethal damage or cell death after extensive damage [l-3] . The role of PARP has been demonstrated in processes that influence cell survival after DNA damage, such as DNA repair [4-81 or expression of growth-related protooncogene c-fos [9-111. The depletion of cellular NAD pool by massive activation of PARP has been considered a cause of metabolic cell death 1121. The recent discovery of proteolytic cleavage of PARP by a protease resembling interleukin-1 P-converting enzyme (prICE) among the early apoptotic events suggests another route through which PARP could be involved in cell death [13, 14] .
The essential role of PARP in cellular recovery after sublethal oxidant damage has not been conclusively established because chemical inhibitors of PARP, such as ben- 0167 .4889/96/$15.00 0 1996 Elsevier Science B.V. All rights reserved PII SOl67-4889(96)00004-3 zamides, cannot significantly decrease cell survival after oxidant damage [15,161. Benzamides are also incomplete inhibitors of induction of c-j&s in cells responding to DNA damage by oxidant [9] and other genotoxic agents (Shah, unpublished data) . Similarly, benzamides cannot inhibit DNA base excision repair processes in vitro [6] . These observations could be correlated to the fact that benzamides are incomplete inhibitors of PARP activity either in vitro [17] or in cells exposed to DNA-damaging agents [I 5,181 . In view of the great abundance of PARP, 80 to 90% inhibition in its activity obtained by benzamides may slow down the cellular functions dependent on PARP by making it a rate-limiting step [19] , but it would not translate into complete inhibition of DNA repair or cellular recovery. This is evident in mutant cell lines, with reduced PARP activity being only marginally more susceptible to DNA damage [20] or having a delay in DNA-repair activity but not an effective inhibition [8] . In contrast, the use of benzamides demonstrated involvement of PARP in cell death after toxic oxidant exposure in different types of cells, such as fibroblasts, macrophages, or lymphocytes . The protection provided by benzamides was attributed to a reduction in the activity of PARP, resulting in conservation of the NAD, glutathione, and ATP pools.
Therefore, use of an inhibitor that could completely prevent PARP activity at noncytotoxic concentrations would clarify the role of PARP in DNA repair and other cellular processes. An exhaustive survey of chemicals for their capacity to inhibit PARP activity in vitro was recently carried out in an effort to find more potent and specific inhibitors of PARP [ 171. We selected 1,5-dihydroxyisoquinoline (DHQ), one of the three potent PARP inhibitors listed in that study, which has a very low IC,, of 0.39 PM toward PARP and a very high IC,, of 890 PM toward mono (ADP-ribosyl) transferase. DHQ was also the only inhibitor to produce 100% inhibition of PARP activity in vitro at a I-mM concentration [ 171 and, of these three inhibitors, it was the least cytotoxic to C3HlOTl/2 cells (unpublished data). Moreover, a similar compound, PD 128763 (3,4-dihydro-5-methyl-1(2H)-isoquinolinone) inhibited the recovery of cells after exposure to X-rays [24] or monofunctional alkylating agent [25] . We present here evidence that cellular recovery after oxidant damage was abolished only when there was a complete inhibition of PARP activity by DHQ. Inhibitory potential of DHQ was analyzed in the in vitro assay for PARP (1350 U/mg), purified up to hydroxyapatite step [26, 27] . In a total reaction mixture of 140 ~1, the inhibitor was incubated at 25°C for 5 min in the presence of 100 mM Tris-HCl, pH 8.0; 10 mM MgCl,; 10% glycerol; 1.5 mM dithiothreitol; 200 PM 32P-NAD (specific activity, 18 mCi/mmol); 10 pg activated DNA; 10 pg total histones. The reaction was carried out with 0.2 U of PARP at 25°C for 2 min and stopped with 100 ~1 of ice-cold 50% trichloroacetic acid (TCA) after the addition of 0.5 mg bovine serum albumin. The TCA-insoluble precipitate containing 32P-pAPDr was collected on GF/C glass fibre filters, washed thoroughly with ethanol, dried, and counted for radioactivity [26] .
Materials and methods

Mouse
Activity blot assay of PARP in vitro
The ability of DHQ to suppress the activity of PARP was also assayed by the activity blot technique according to Shah et al. [26] . Samples were electrophoresed on a sodium dodecyl sulfate/polyacrylamide minigel (8% w/v), and the gels were soaked at 37°C in 0.7 M @-mercaptoethanol;
190 mM glycine; 25 mM Tris-HCl, pH 8.0; and 0.1% sodium dodecyl sulfate, before electrotransfer on a nitrocellulose membrane. The enzymatic activity of PARP was detected by its ability to synthesize 32P-pADPr from the substrate 32 P-NAD, as described earlier [28, 29] . Nitrocellulose membranes were soaked for 1 h in 10 ml of renaturation buffer (50 mM Tris-HCl, pH 8.0; 100 mM NaCl; 1 mM dithiothreitol; 0.3% Tween 20) containing 2 pg/ml activated DNA, 20 PM Zn(I1) acetate, and 2 mM MgCl,. When required, the blots were incubated with the inhibitor for 15 min in the renaturation buffer. The enzymatic activity was carried out for 1 h with 2 pCi/ml of 32 P-NAD. Unprocessed 32P-NAD was removed by four washes for 15 min with 20 ml of renaturation buffer. The blots were dried and analyzed by autoradiography using Kodak X-OMAT AR5 films to visualize the labeled, automodified PARP.
Analysis of pADPr and NAD levels in cells
C3HlOT1/2 cells were labeled with 3H-Ade, which is incorporated in the NAD pool, and oxidant-induced 3H-pADPr synthesized in these cells was isolated and analyzed as 3H-ribosyladenosine (RAdo) [26, 301 . Confluent monolayers of C3HlOT1/2 cells were incubated in 5 ml of complete medium containing 20 &i/ml of 3H-Ade for 16 h. The cells were incubated with DHQ for 1 h before exposure to X/X0 (lOO/lO pg/ml for 30 min) in the serum-free medium. The cells were washed twice with cold phosphate buffered saline and harvested with 2 X 1 ml 20% TCA (4°C) for 15 min at 4°C. The TCA pellet was collected at 1000 X g for 10 min at 4°C and processed for pAPDr analysis [26] . Specific activity of NAD pool in the TCA supernatant was analyzed after purification through dihydroxyboronyl Bio-Rex (DHBB) chromatography followed by a cycling microassay for NAD as recently described by us [26] .
The protein-bound 3H-pADPr in the TCA pellet was dissolved in formic acid, and precipitated with 20% TCA (4°C 15 min) after the addition of 1 mg bovine serum albumin and a spike of 1 nmol of cold pADPr. After centrifugation for 10 min at 1000 X g and 4°C the TCAinsoluble pellet was processed further to isolate and analyze pADPr essentially as described by Shah et al. [26] . In brief, 3H-pADPr was separated from the proteins by digestion at 37°C for 2 h with 1 M KOH, 50 mM EDTA, and purified by dihydroxyboronyl BioRex (DHBB) chromatography. The 'H-pADPr preparation was digested at 37°C for 2 h with 25 U of RNase A to remove any contaminating RNA. It was then digested at 37°C overnight with 0.25 U of snake venom phosphodiesterase and 2.5 U of bacterial alkaline phosphatase to form 'H-RAdo or diribosyladenosine. 3H-RAdo was resolved from other nucleosides by HPLC [31] on a C,, reverse-phase column (5 pm, 4.6 X 150 mm) isocratically eluted at 30°C at 1 ml/min with 7 mM ammonium formate, pH 5.8, containing 6% methanol. After UV detection at 254 nm, radioactivity in the effluent was monitored by an on-line detector after mixing with 4 volumes of PCS liquid scintillation cocktail (Amersham, Oakville, Ont., Canada). The retention times of Ado, dAdo, and RAdo were 22, 26, and 32 min, respectively [26] . The endogenous RAdo was estimated from radioactivity present in the RAdo peak and from the specific activity of the 3H-NAD pool in the cells. Our improvements [26] over the original technique 1311 enabled us to detect small quantities of pADPr formed in the control samples.
Assay of clonogenicity
Cell survival after oxidant exposure was measured by the standard clonogenic assays [32] . In brief, the cells were incubated in complete medium for 16 h with DHQ or solvent DMSO and exposed for 30 min to X/X0 (lOO/ 10 pg/ml) in the presence of DHQ in serum-free medium.
The cells were allowed to recover for 24 h in complete medium containing the inhibitor, rinsed with phosphate buffered saline, trypsinized, counted, and redistributed in 60-mm petri dishes in triplicate. Plating efficiency was determined as the percentage of the seeded cells that formed colonies after 10 days. The relative colony-forming ability (% RCFA) was calculated from the plating efficiency of treated cells compared with control cells [32] .
Results
I. DHQ, a potent inhibitor of PARP actiuity in vitro
We observed that DHQ (IC,,: N 0.3 PM) was at least 30-fold more effective in inhibiting PARP activity in vitro than benzamide (Fig. 1) . As our interest was in total inhibition of PARP activity, the data for reduction of PARP activity at low concentrations ( < 10 PM) of benzamide are not presented here. Furthermore, a complete inhibitory profile of benzamide has been characterized by Rankin et al. [19] . The inhibition observed with 100 PM DHQ was more complete than that with 1 mM benzamide (Fig. 1) . This finding was further confirmed in the activity blot assay of PARP (Fig. 2) . The amount of radioactivity present at * 116 kDa reflects the activity of PARP resulting in its automodification with 32P-pADPr (Fig. 2, lane  1) . Nearly complete inhibition of PARP activity was observed at 10 to 100 PM DHQ compared with 500 to 1000 PM 3-aminobenzamide required for a similar effect (Fig.  2 , lanes 8 and 9 compared with lanes 4 and 5). Thus, DHQ was at least 10 to 50 times more potent an inhibitor of PARP activity compared with 3-aminobenzamide.
DHQ inhibits oxidant-induced pADPr synthesis in intact cells
We previously observed that 1 mM benzamide was unable to inhibit completely the accumulation of pADPr in C3HlOTl/2 cells exposed to an oxidant [15, 33] . Therefore, the potency of DHQ to inhibit oxidant-induced pADPr synthesis was tested in these cells (Fig. 3) . The pADPr levels, which were very low in control cells (N 7 pmol RAdo /lOa cells), increased 115-fold on exposure to X/X0.
Treatment of cells at 0.01 and 0.1 mM DHQ brought about 95 and 98% reductions in oxidant-induced pADPr levels, respectively. Although these are significant decreases, the pADPr levels in cells treated with 0.1 mM DHQ were still 1.7-fold greater than in the controls. The oxidant-induced pADPr levels were totally suppressed (60% of control) only at 1 mM DHQ. Basal polymer synthesis was not affected by 1 mM DHQ. A similar inhibitory profile of DHQ was observed with H,O,-induced pADPr synthesis in these cells (data not shown), indicating the effectiveness of DHQ in inhibiting oxidantinduced pADPr synthesis.
Total inhibition of pADPr synthesis preuents recovery qf cells after oxidant exposure
Our previous studies demonstrated benzamides to be incapable of reducing the viability of oxidant-exposed C3HlOT1/2 cells [ 151. Therefore, the inhibitory capacity of DHQ on the plating efficiency of these cells after oxidant damage was analyzed (Fig. 4) . Exposure to X/X0 per se decreased the RCFA to 40% of control values (Fig.  4A,B) . Additional exposure to 0.0 1 or 0.1 mM DHQ could not decrease the RCFA as significantly (Fig. 4C,D ) as the drop in pADPr level (Fig. 3) . In contrast, cellular recovery from oxidant shock was almost completely inhibited by 1 mM DHQ (Fig. 4E) . This inhibition was not because of [Inhibitor] pM Fig. I . Effect of DHQ and benzamide on PARP activity in vitro was assayed by its ability to incorporate "P-NAD into " P-pADPr in the presence of activated DNA. The reaction was terminated by TCA, and the acid-insoluble '* P-pADPr was harvested on GF/C glass fibre filters and counted for radioactivity. PARP activity in the absence of any inhibitor (solvent control) was 27.9+ 1.3 (mean+S.D.; n = 6; considered 100% PARP activity) pmol '* P-NAD incorporated in TCA-insoluble precipitate under standard assay conditions. The inhibitors were preincubated for 5 min before addition of the enzyme. Effect of inhibitor on PARP activity is expressed as percentage of controls and values are mean + S.D. of four independent experiments.
3-AB (PM)
DHQ ( cytotoxicity of the inhibitor, as there was only -20% reduction in RCFA at 1 mM DHQ with no significant effect on RCFA below I-mM concentrations (Fig. 4F-H) . The lack of toxic effect of DHQ in these cells was further confirmed because the control cells exposed to 1 mM DHQ for 16 h, exhibited a transient decrease in metabolic activity, measured by the tetrazolium-based calorimetric assay [34] , but there was no significant change in the proportion of cells in each phase of the cell cycle up to 48 h after exposure to the inhibitor (data not shown).
Discussion
The inability of benzamides to reduce the viability of oxidant-exposed fibroblasts [ 151 does not correspond with the role of PARP in processes that influence cell survival, such as DNA repair. However, because of the great abundance of PARP in the nucleus, its incomplete inhibitors, such as benzamides, would allow residual activity of PARP, which may be sufficient for most cellular functions. We clearly show here that a very low level (l-5%) of PARP activity would be sufficient to allow the cell to recover from sublethal oxidative damage (Figs. 3 and 4 ). We also demonstrate that cellular recovery is completely abolished only when PARP activity is totally inhibited. It was estimated that even minor automodification i.e., 2-3 ADPribose residues per modification site would prevent PARP from reattaching to DNA and render it incapable of blocking DNA repair [6] . This is reflected in the continuation of DNA repair [6] or cellular survival after oxidant damage [15] in the presence of low-level PARP activity. In contrast, DHQ can abolish cellular recovery after oxidant damage, and we suggest that this may arise from its capacity to completely block the role of PARP in DNA repair.
PARP may also be a major participant in other cellular recovery processes downstream from DNA repair, for example, activation of growth-related proto-oncogenes cfos or c-myc [35] . In mouse epidermal fibroblasts, through the use of benzamides, the induction of c-f& after direct or indirect oxidative damage was shown to be partially dependent on PARP [9, 10] . The potent inhibitor DHQ may inhibit the activation of these genes, as observed with inhibitors of protein kinase C [9,10]. As expression of these genes is linked to cellular recovery and growth, the lack of cell survival in the total absence of PARP activity may arise from the role of PARP in activation of these genes.
Different studies [24, 25, 37, 38] carried out with DHQ or PD128763 (which is also an isoquinoline)
indicate an absence of nonspecific side effects, such as an alteration in nucleotide metabolism, observed for benzamides [36] . This is the first report on the effects of DHQ on pADPr metabolism in mouse embryo fibroblasts and its subsequent effects on cell survival. Other studies have reported that DHQ-mediated inhibition of PARP results in reduced nitric oxide toxicity in neuronal cells [37] or increased antibody class switching in B cell lymphomas [38] . No toxicity has been reported for PD 128763, an isoquinoline compound similar to DHQ, during studies with L1210 cells or Chinese hamster V79 cells (24, 251 . Also, we did not observe any DHQ cytotoxicity in mice, fish, or different cultured cell lines at concentrations that are effective in inhibiting pADPr synthesis. The possible noncytotoxic effect of DHQ on other cellular processes or enzymes that affect cell survival, however, needs to be explored.
Oxidant-mediated cell death is believed to involve the activation of PARP, resulting in the depletion of NAD and ATP or glutathione pools of the cell [22, 23] . 1 mM DHQ did not affect NAD, NADP or ATP pools, however glu- tathione pools were increased thus suggesting more antioxidant defense. Therefore, a 90 to 95% inhibition in PARP activity by benzamides could significantly reduce cell killing by toxic concentrations of oxidant. At sublethal concentrations of oxidants used in these studies, DHQ did not protect the cells from oxidant damage, because 95 to 98% reduction in PARP activity could not significantly increase the RCFA (Figs. 3 and 4) . Therefore, the cell death observed at 1 mM DHQ, as a result of the potentiation of oxidant damage, occurs in the absence of PARPmediated repair pathways such as those happening in base excision repair (4,5) and thus does not appear to be caused by a decrease of ATP, NAD, NADP, or glutathione pools. In the absence of inhibitor during the last 10 days of the survival assay, normal PARP activity is expected in the phase during which the cells either die or recover to form colonies.
Inhibitors of PARP have varying effects on different cells because of differences in effective intracellular concentrations of the inhibitor [ 19,2 1,361 . These variations can be further influenced during oxidant damage by the presence of other factors involved in antioxidant defense in the cell [22] . Thus, 10 /.LM of DHQ could be effective in inhibiting nitric oxide-mediated neurotoxicity [37], whereas 0.5 to 1 mM of DHQ or related compounds are needed to inhibit the recovery of Chinese hamster V79 or L12 10 cells after damage by X-rays or alkylating agents [24, 25] or of C3HlOT1/2 cells after oxidant damage, as shown here.
In this study, we demonstrated that complete inhibition of PARP activity by DHQ reveals the role of PARP in cellular recovery after oxidant damage. The recovery of cells in presence of even a minor fraction of the PARP activity should be carefully considered while studying PARP by other approaches, such as trans-dominant inhibition or mutant cell lines with reduced PARP activity. More studies with DHQ in processes such as apoptosis, DNA repair, or recombination and in cellular survival after different types of DNA damage could help define the role of PARP in these cellular processes. . Effect of DHQ on clonogenicity of C3HlOTl/2 cells exposed to oxidants. Plating efficiency, that is, the % of cells seeded that form colonies, was measured after treatment with oxidant (X/X0) and/or DHQ. The effect of the inhibitor was expressed as relative colony forming ability (RCFA), i.e., plating efficiency of experimental group as % of DMSO-treated control, which was 27 f 3 (mean & SD.; n = 6, 100% RCFA). In two separate experiments, cells for each treatment group were plated in triplicate, at high and low cell densities to obtain accurate count of plating efficiency even at higher concentration of the inhibitors. Results (mean * S.D., n = 6) are expressed as RCFA (8 control).
